Patents Assigned to Theranos, Inc.
-
Publication number: 20130078624Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: ApplicationFiled: September 26, 2011Publication date: March 28, 2013Applicant: Theranos, Inc., a Delaware CorporationInventors: Elizabeth Holmes, Sunny Balwani
-
Publication number: 20130078733Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: ApplicationFiled: September 26, 2011Publication date: March 28, 2013Applicant: Theranos, Inc., a Delaware CorporationInventors: Elizabeth Holmes, Joy Roy, John Kent Frankovick
-
Patent number: 8392585Abstract: Methods and systems are provided for connecting an electronic device to a network. In some situations, the electronic device connects to a first network provider and pings a first server having a static internet protocol address and a second server having a dedicated uniform resource locator. If the electronic device receives a response from the first and second server, the electronic device maintains its connection to the first network provider. Otherwise, the electronic device connects to a second network provider and pings the first and second servers.Type: GrantFiled: September 26, 2011Date of Patent: March 5, 2013Assignee: Theranos, Inc.Inventor: Sunny Balwani
-
Patent number: 8380541Abstract: Systems and methods are provided for collecting, preparing, and/or analyzing a biological sample. A sample collection site may be utilized with one or more sample processing device. The sample processing device may be configured to accept a sample from a subject. The sample processing device may perform one or more sample preparation step and/or chemical reaction involving the sample. Data related to the sample may be sent from the device to a laboratory. The laboratory may be a certified laboratory that may generate a report that is transmitted to a health care professional. The health care professional may rely on the report for diagnosing, treating, and/or preventing a disease in the subject.Type: GrantFiled: September 26, 2011Date of Patent: February 19, 2013Assignee: Theranos, Inc.Inventor: Elizabeth Holmes
-
Patent number: 8283155Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.Type: GrantFiled: October 8, 2009Date of Patent: October 9, 2012Assignee: Theranos, Inc.Inventors: Elizabeth A. Holmes, Shaunak Roy, John Howard, Chengwang Wang, Ian Gibbons, Timothy M. Kemp, Shize Daniel Qi
-
Patent number: 8265955Abstract: Described herein are methods and systems useful for characterizing clinical outcomes of a subject. Provided herein includes computer-assessed methods, medical information systems, and computer-readable instructions that can aid an end-user in diagnosis, prognosis, and treatment of a clinical outcome.Type: GrantFiled: September 26, 2011Date of Patent: September 11, 2012Assignee: Theranos, Inc.Inventors: Seth Michelson, Timothy Michael Kemp, Ian Gibbons, Elizabeth A. Holmes
-
Patent number: 8202697Abstract: The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device.Type: GrantFiled: August 12, 2005Date of Patent: June 19, 2012Assignee: Theranos, Inc.Inventor: Elizabeth A. Holmes
-
Patent number: 8158430Abstract: The present invention provides fluidic devices and systems that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.Type: GrantFiled: August 6, 2008Date of Patent: April 17, 2012Assignee: Theranos, Inc.Inventors: Shaunak Roy, Malissa Takahashi, Ian Gibbons, Edmond Ku, Thanh Dang, Tammy Burd, Adam Vollmer, Elizabeth A. Holmes
-
Patent number: 8101402Abstract: The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device.Type: GrantFiled: August 12, 2005Date of Patent: January 24, 2012Assignee: Theranos, Inc.Inventor: Elizabeth A. Holmes
-
Patent number: 8088593Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.Type: GrantFiled: October 2, 2008Date of Patent: January 3, 2012Assignee: Theranos, Inc.Inventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
-
Patent number: 8012744Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.Type: GrantFiled: October 13, 2006Date of Patent: September 6, 2011Assignee: Theranos, Inc.Inventors: Ian Gibbons, Michael O'Connell
-
Patent number: 8008034Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications. In particular, the medical device reduces interference with an optical signal which is indicative of the presence of an analyte in a bodily sample.Type: GrantFiled: March 13, 2007Date of Patent: August 30, 2011Assignee: Theranos, Inc.Inventors: Ian Gibbons, Michael O'Connell
-
Patent number: 8007999Abstract: The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.Type: GrantFiled: May 9, 2007Date of Patent: August 30, 2011Assignee: Theranos, Inc.Inventors: Elizabeth A. Holmes, Ian Gibbons
-
Publication number: 20110093249Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.Type: ApplicationFiled: October 18, 2010Publication date: April 21, 2011Applicant: Theranos, Inc.Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel L. Young, Seth G. Michelson
-
Patent number: 7888125Abstract: The present invention provides methods of calibrating a fluidic device useful for detecting an analyte of interest in a bodily fluid. The invention also provides methods for assessing the reliability of an assay for an analyte in a bodily fluid with the use of a fluidic device. Another aspect of the invention is a method for performing a trend analysis on the concentration of an analyte in a subject using a fluidic device.Type: GrantFiled: March 24, 2006Date of Patent: February 15, 2011Assignee: Theranos, Inc.Inventors: Ian Gibbons, Chengwang Wang, Shaunak Roy, Elizabeth A. Holmes
-
Patent number: 7635594Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.Type: GrantFiled: March 24, 2006Date of Patent: December 22, 2009Assignee: Theranos, Inc.Inventors: Elizabeth A. Holmes, Shaunak Roy, John Howard, Chengwang Wang, Ian Gibbons, Timothy M. Kemp, Shize Daniel Qi
-
Patent number: 7291497Abstract: The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device.Type: GrantFiled: September 10, 2004Date of Patent: November 6, 2007Assignee: Theranos, Inc.Inventors: Elizabeth A. Holmes, Shaunak Roy, John Howard, Chengwang Wang